The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Thresholds for the cost–effectiveness of interventions: alternative approaches
Open accessAbstract
Many countries use the cost-effectiveness thresholds recommended by the World Health Organization's Choosing Interventions that are Cost-Effective project (WHO-CHOICE) when evaluating health interventions. This project sets the threshold for cost-effectiveness as the cost of the intervention per disability-adjusted life-year (DALY) averted less than three times the country's annual gross domestic product (GDP) per capita. Highly cost-effective interventions are defined as meeting a threshold per DALY averted of once the annual GDP per capita. We argue that reliance on these thresholds reduces the value of cost-effectiveness analyses and makes such analyses too blunt to be useful for most decision-making in the field of public health. Use of these thresholds has little theoretical justification, skirts the difficult but necessary ranking of the relative values of locally-applicable interventions and omits any consideration of what is truly affordable. The WHO-CHOICE thresholds set such a low bar for cost-effectiveness that very few interventions with evidence of efficacy can be ruled out. The thresholds have little value in assessing the trade-offs that decision-makers must confront. We present alternative approaches for applying cost-effectiveness criteria to choices in the allocation of health-care resources.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In a separate health economics analysis (unpublished), we found that single-dose HPV vaccination with catch-up vaccination in girls aged 11–20 years could be cost-effective under the WHO recommended cost-effectiveness threshold of one-times gross domestic product per capita.”
From Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study (2022) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
The World Health Report 2002 - Reducing Risks, Promoting Healthy Life
Available, N. A. N. (2003) · Education for Health · doi:10.1080/1357628031000116808 · Cited by 6,078
Methods for the economic evaluation of health care programmes
Wilson, S. (1987) · Journal of Epidemiology & Community Health · doi:10.1136/jech.41.4.355-a · Cited by 4,312
Cost-Benefit Analysis: Concepts and Practice
Boardman, A. E., Greenberg, D. H., Vining, A. R., & Weimer, D. L. (1996) · Cited by 1,920
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., Loder, E., et al. (2013) · BMJ · doi:10.1136/bmj.f1049 · Cited by 1,776
Methods for the economic evaluation of health care programmes, 3rd ed
Adamiak, G. T. (2006) · PubMed Central · Cited by 953
The Value of Life and the Rise in Health Spending
Hall, R. E., & Jones, C. I. (2007) · The Quarterly Journal of Economics · doi:10.1162/qjec.122.1.39 · Cited by 924
Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard
Hirth, R. A., Chernew, M. E., Miller, E., Fendrick, A. M., & Weissert, W. G. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000310 · Cited by 850
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
Thorlund, K., Devereaux, P. J., Wetterslev, J., Guyatt, G. H., Ioannidis, J. P. A., Thabane, L., Gluud, L. L., Als-Nielsen, B. E. T., & Gluud, C. N. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dyn179 · Cited by 834
Robinson, R. (1993) · BMJ · doi:10.1136/bmj.307.6907.793 · Cited by 819
Cited by
Sorted by citations
Items 401–500 of 853
Cost-Effectiveness Analysis of High-Risk Groups Tuberculosis Screening in Malaysia
Hassan, N. Z. A. M., Razali, A., Shahari, M. R., Kunusagaran, M. S. J. M. N. S., Halili, J., Zaimi, N. A., Bahari, M. S., & Aminuddin, F. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.699735 · Cited by 10
Bianculli, P. M., Bellier, L., Olivera, I., Pérez, C. G., Mieres, G., Lazarov, L., Petitjean, A., Dibarboure, H., & López, J. G. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2050653 · Cited by 10
Hinde, J. M., Garner, B. R., Watson, C. J., Ramanan, R., Ball, E. L., & Tueller, S. (2022) · Implementation Research and Practice · doi:10.1177/26334895221089266 · Cited by 10
Chugh, Y., Jyani, G., Trivedi, M., Albert, S., Kar, S. S., Patro, B. K., Raman, S., Rajsekar, K., Baker, R. M., Donaldson, C., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-065591 · Cited by 10
Ahmed, M., Muhoozi, G. K. M., Atukunda, P., Westerberg, A. C., Iversen, P. O., & Wangen, K. R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290379 · Cited by 10
Home-based versus center-based care in children with cerebral palsy: a cost-effectiveness analysis.
Azar, E. S., Ravanbakhsh, M., Torabipour, A., Amiri, E., & Haghighyzade, M. H. (2015) · Europe PMC (PubMed Central) · Cited by 10
HEALTH TECHNOLOGY ASSESSMENT IN EVALUATION OF PHARMACEUTICALS IN THE CZECH REPUBLIC
Vostalová, L., Mazelová, J., Samek, J., & Vocelka, M. (2017) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462317000204 · Cited by 10
Cost-Effectiveness and Budget Impact of Lumacaftor/Ivacaftor in the Treatment of Cystic Fibrosis
Vadagam, P., Kamal, K. M., Covvey, J. R., Giannetti, V. J., & Mukherjee, K. (2018) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2018.24.10.987 · Cited by 10
Explicit Cost-Effectiveness Thresholds in Health Care: A Kaleidoscope
Luyten, J., & Denier, Y. (2018) · Social Justice Research · doi:10.1007/s11211-018-0322-9 · Cited by 10
Anderson, J. D., Muhib, F., Rheingans, R., & Wierzba, T. F. (2019) · Vaccine X · doi:10.1016/j.jvacx.2019.100043 · Cited by 10
Harrell, S., Pillarisetti, A., Roy, S., Ghorpade, M., Patil, R., Dhongade, A., Smith, K. R., Levine, D. I., & Juvekar, S. K. (2020) · Environmental Science & Technology · doi:10.1021/acs.est.0c01818 · Cited by 10
Švihra, J., Sopilko, I., Švihrová, V., Študent, V., & Ľupták, J. (2020) · Urolithiasis · doi:10.1007/s00240-020-01224-4 · Cited by 10
Shepard, D. S., Halasa‐Rappel, Y. A., Zeng, W., Rowlands, K. R., & Musange, S. (2023) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.22-0519 · Cited by 10
Borissov, B., Urbich, M., Georgieva, B., Tsenov, S., & Villa, G. (2017) · Journal of Market Access & Health Policy · doi:10.1080/20016689.2017.1412753 · Cited by 10
Mateti, U. V., Nagappa, A. N., Attur, R. P., Nagaraju, S. P., & Rangaswamy, D. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1504595 · Cited by 10
Impact of a New Cost-Effectiveness Threshold Implementation on Cancer Formulary Decisions in Jordan
Treish, I. M., Rabayah, A. A., Jaddoua, S. M., & Tuffaha, H. (2021) · PharmacoEconomics - Open · doi:10.1007/s41669-021-00293-4 · Cited by 9
Estimating a cost-effectiveness threshold for healthcare decision-making in the Greek NHS
Athanasakis, K., Agorastos, G., & Kyriopoulos, I. (2024) · Health Policy and Technology · doi:10.1016/j.hlpt.2024.100882 · Cited by 9
Cai, Q., You, S., Huang, J., Gong, C., Zhang, W., & Zhou, A. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2468070 · Cited by 9
Chugh, Y., Jyani, G., Kar, S. S., Patro, B. K., Trivedi, M., Albert, S., Raman, S., Rajsekar, K., Prinja, S., Goyal, A., et al. (2025) · Value in Health · doi:10.1016/j.jval.2025.10.007 · Cited by 9
Sidiropoulou, Z., & Fonseca, V. (2025) · Cancers · doi:10.3390/cancers17213585 · Cited by 9
Hart, J., Kalua, K., Keenan, J. D., Lietman, T. M., & Bailey, R. L. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.19-0622 · Cited by 9
Bogdewic, S., Ramaswamy, R., Goodman, D. M., Srofenyoh, E., Ucer, S., & Owen, M. D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242170 · Cited by 9
Urueña, A., Micone, P., Magneres, M. C., McGovern, I., Mould-Quevedo, J. F., Sarmento, T. T. R., & Giglio, N. (2022) · Vaccines · doi:10.3390/vaccines10101627 · Cited by 9
Taylor, E., Prada, J. M., Vilas, V. D. R., Undurraga, E. A., Wallace, R. M., & Horton, D. L. (2023) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.22-0308 · Cited by 9
Cousins, M., Parmley, E. J., Greer, A. L., Neiterman, E., Lambraki, I. A., Vanderheyden, M. N., Wernli, D., Jørgensen, P. S., Carson, C. A., & Majowicz, S. E. (2024) · Research Directions One Health · doi:10.1017/one.2023.15 · Cited by 10
Prices For Common Cardiovascular Drugs In The US Are Not Consistently Aligned With Value
Campbell, J. D., Belozeroff, V., Whittington, M. D., Rubin, R. J., Raggi, P., & Briggs, A. H. (2018) · Health Affairs · doi:10.1377/hlthaff.2018.0221 · Cited by 9
Evidence‐Based Medicine in Otolaryngology Part 9: Valuing Health Outcomes
Caulley, L., Hunink, M. G. M., Kilty, S., Metha, V., Scangas, G. A., Rodin, D. L., Randolph, G. W., & Shin, J. J. (2018) · Otolaryngology · doi:10.1177/0194599818800477 · Cited by 11
Evidence‐Based Medicine in Otolaryngology Part 10: Cost‐Effectiveness Analyses in Otolaryngology
Caulley, L., Rodin, D. L., Kilty, S., Randolph, G. W., Hunink, M. G. M., & Shin, J. J. (2019) · Otolaryngology · doi:10.1177/0194599819852104 · Cited by 9
Salikhanov, I., Crape, B. L., & Howie, P. (2019) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2019.20.10.3153 · Cited by 9
Jiang, Y., Jiang, S., & Ni, W. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-003160 · Cited by 9
QALY league table of Iran: a practical method for better resource allocation
Hashempour, R., Raei, B., Lari, M. S., Gallehzan, N. A., & Akbarisari, A. (2021) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-020-00256-2 · Cited by 9
Polly, D. W., Larson, A. N., Samdani, A. F., Rawlinson, W. D., Brechka, H., Porteous, A., Marsh, W. J., & Ditto, R. (2021) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s289459 · Cited by 9
Cost-Effectiveness of Colorectal Cancer Genetic Testing
Ramdzan, A. R., Manaf, M. R. A., Aizuddin, A. N., Latiff, Z. A., Teik, K. W., Ch’ng, G.-S., Ganasegeran, K., & Aljunid, S. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168330 · Cited by 9
Leemans, G., Taeymans, J., Royen, P. V., & Vissers, D. K. (2021) · Journal of physiotherapy · doi:10.1016/j.jphys.2021.08.018 · Cited by 9
Johnson, B., Lai, E. C., Ou, H., Li, H., & Stollenwerk, B. (2021) · Archives of Osteoporosis · doi:10.1007/s11657-021-01020-6 · Cited by 9
Economic Evaluation of Universal Varicella Vaccination in Mexico
Chacon-Cruz, E., Meroc, E., Clemens, S. A. C., Clemens, R., & Verstraeten, T. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003448 · Cited by 9
Tejada, R. A., Malagón, T., & Franco, E. L. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.03.046 · Cited by 12
Lau, E. S. H., Salem, A. M. H., Chan, J. C. N., So, W. Y., Kong, A. P. S., Lamotte, M., & Luk, A. O. Y. (2019) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-019-0180-9 · Cited by 9
Yuen, M., Liu, S.-H., Seto, W., Mak, L., Corman, S. L., Hsu, D. C., Lee, M. Y. K., Khan, T. K., & Puenpatom, A. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06281-8 · Cited by 9
Hassan, M. Z., Biswas, M. A. A. J., Shirin, T., Rahman, M., Chowdhury, F., Azziz‐Baumgartner, E., Davis, W. W., & Hussain, M. (2024) · Journal of Global Health · doi:10.7189/jogh.14.04126 · Cited by 8
Wittenberg, R., Anderson, R., Redding, S., Gopal, B. K., Sadanandan, R., Sahasranamam, V. I., George, S., Premnazir, L., Netuveli, G., Srinath, J., et al. (2024) · Eye · doi:10.1038/s41433-024-03304-w · Cited by 8
Alenazi, A., Alotaibi, B., Madan, J. J., Yeung, J., Johnson, S., & Couper, K. (2025) · Resuscitation · doi:10.1016/j.resuscitation.2025.110822 · Cited by 7
Agwu, C., Purcell, L. N., Gallaher, J. R., Young, S., Banza, L. N., Mansfield, A. J., & Charles, A. G. (2020) · Injury · doi:10.1016/j.injury.2020.11.002 · Cited by 8
Duan, K. I., Garza, F. R., Flores, H., Palazuelos, D., Maza, J., Martínez‐Juárez, L. A., Elliott, P. F., Lázaro, E. M., Enríquez-Ríos, N., Nigenda, G., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046826 · Cited by 8
Por, E. D., Selig, D. J., Chin, G. C., DeLuca, J. P., Oliver, T. G., & Livezey, J. (2021) · Military Medicine · doi:10.1093/milmed/usab098 · Cited by 8
Understanding Health Economics in Joint Replacement Surgery
Glasser, J., Patel, S. A., Li, N. Y., Patel, R. A., Daniels, A. H., & Antoci, V. (2022) · Orthopedics · doi:10.3928/01477447-20220401-02 · Cited by 8
Michaelson‐Cohen, R., Cohen, M. J., Cohen, C., Greenberg, D., Shmueli, A., Lieberman, S., Tomer, A., Levy‐Lahad, E., & Lahad, A. (2022) · Cancers · doi:10.3390/cancers14246113 · Cited by 8
Jamshidi, A., Daroudi, R., Aas, E., & Khalili, D. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1075277 · Cited by 8
Motta-Santos, A. S., Noronha, K., Reis, C. D. B., Freitas, D., Carvalho, L. M. D. A., & Andrade, M. V. (2024) · Value in Health Regional Issues · doi:10.1016/j.vhri.2024.02.002 · Cited by 9
Yogendrakumar, V., Balabanski, A. H., Johns, H. T., Churilov, L. P., Parsons, N. K., Beharry, J., Weir, L. C., Yassi, N., Zhao, H. H., Warwick, A., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.036856 · Cited by 8
Xiang, Z., Li, Z., Chen, X., & Fu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1562875 · Cited by 8
Li, J., Wen, Z., Cai, A., Tian, F., Liang, Z., Luo, X., Li, D., He, J., Yang, Y., & Chen, W. (2016) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2016-0086 · Cited by 8
Moradi‐Lakeh, M., Yaghoubi, M., Hajebi, A., Malakouti, S. K., & Vasfi, M. G. (2017) · Health & Social Care in the Community · doi:10.1111/hsc.12416 · Cited by 8
Du, X., He, X., Jia, Y., Wu, J., Long, D., Yu, R., Sang, C., Yin, H., Xuan, J., Dong, J., et al. (2019) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00349-1 · Cited by 8
Gómez‐Casares, M. T., Hernández‐Boluda, J. C., Jiménez‐Velasco, A., Martínez‐López, J., Ferrario, M. G., Gozalbo, I., Gostkorzewicz, J., & Subirà, R. (2017) · Journal of health economics and outcomes research · doi:10.36469/9808 · Cited by 8
Lee, M.-C., Liao, C., Toh, H. S., Chou, C.-C., Chang, W., Chen, Z., Wu, W.-S., Yu, T., & Strong, C. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07059-w · Cited by 8
Salem, A. M. H., Men, P., Ramos, M., Zhang, Y., Ustyugova, A., & Lamotte, M. (2021) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2020-0284 · Cited by 8
Beilby, H., Yang, F. B., Gannon, B., & McIntyre, D. H. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1973415 · Cited by 8
Obeng-Kusi, M., Habila, M. A., Roe, D. J., Erstad, B. L., & Abraham, I. (2021) · Journal of Medical Economics · doi:10.1080/13696998.2021.2002092 · Cited by 8
Tatar, M., Alkış, N., Güçlü, Ç. Y., Bermede, O., Erdemli, B., & Günaydın, S. (2022) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s360944 · Cited by 8
Cost-Effectiveness Analysis of Rivaroxaban in Chinese Patients With Stable Cardiovascular Disease
Feng, T., Zheng, Z., Gao, S. B., Xu, J., Cao, P., Jia, H., & Yu, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.921387 · Cited by 8
Magalhães, M. A. F., Aguiar, P. N., Neves, M. B. M., Lopes, G. D. L., Jr., & del Giglio, A. (2022) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2022gs6655 · Cited by 8
Ramos, J. R., Juanes-Borrego, A. M., Puig, M., Andión, M. B., López-Vinardell, L., Gilabert-Perramon, A., Segura, J. M. G., & Mangues, M. A. (2022) · International Journal of Pharmacy Practice · doi:10.1093/ijpp/riac061 · Cited by 8
Gomes, I., Dong, C.-R., Vandewalle, P., Khan, A. R., Creswell, J., Dowdy, D. W., & Sohn, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270816 · Cited by 8
Al‐Shaibi, S., Abushanab, D., Abounahia, F. F., Awaisu, A., & Al‐Badriyeh, D. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101751 · Cited by 8
Tchétché, D., de Gennes, C. D., Cormerais, Q., Geisler, B. P., Dutot, C., Wilquin-Bequet, F., Breau-Brunel, M., Lueza, B., & Pietzsch, J. B. (2023) · The European Journal of Health Economics · doi:10.1007/s10198-023-01590-x · Cited by 8
Cost-effectiveness of a pediatric operating room installation in Sub-Saharan Africa
Yap, A., Halid, S. I., Ukwu, N., Laverde, R., Park, P., Klazura, G., Bryce, E., Cheung, M., Marseille, E. A., Ozgediz, D., et al. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001748 · Cited by 11
Self-citationAn Introduction to Economic Analysis of Food Security and Nutrition Interventions
Adams, K. P., Lee, J. A., Piltch, E. M., & Jimenez, E. Y. (2019) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.11.015 · Cited by 8
Wilson, N., Davies, A., Brewer, N., Nghiem, N., Cobiac, L. J., & Blakely, T. A. (2019) · Population Health Metrics · doi:10.1186/s12963-019-0192-x · Cited by 8
Purba, A. K. R., Ascobat, P., Muchtar, A., Wulandari, L., Dik, J.-W. H., d’Arqom, A., & Postma, M. J. (2019) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s224619 · Cited by 8
Advocating an attack against severe malaria: a cost-effectiveness analysis
Greenhalgh, S., & Chandwani, V. (2020) · BMC Public Health · doi:10.1186/s12889-019-8141-y · Cited by 8
Cost effectiveness of a novel device for improving resuscitation of apneic newborns
Ali, A., Nudel, J., Heberle, C. R., Santorino, D., Olson, K. R., & Hur, C. (2020) · BMC Pediatrics · doi:10.1186/s12887-020-1925-5 · Cited by 8
Money and my mind: Maternal cash transfers and mental health
Okeke, E. N. (2021) · Health Economics · doi:10.1002/hec.4398 · Cited by 8
Li, E. C. K., Tagoola, A., Komugisha, C., Nabweteme, A. M., Pillay, Y., Ansermino, J. M., & Khowaja, A. R. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-09977-5 · Cited by 7
Cardiovascular health and economic outcomes under improved air quality in China: a modelling study
Wang, S., Jiang, Y., Xu, Z., Tanna, G. L. D., Lewis, S., Chen, M., Downey, L. E., Jan, S., & Si, L. (2024) · BMJ Global Health · doi:10.1136/bmjgh-2024-016974 · Cited by 7
Wong, N. S., Chan, D. P., Wong, G. L., & Lee, S. S. (2025) · Journal of Viral Hepatitis · doi:10.1111/jvh.70027 · Cited by 7
Pichón-Rivière, A., Cairoli, F. R., Drummond, M., Espínola, N., Martí, S. G., & Augustovski, F. (2025) · The Lancet Global Health · doi:10.1016/s2214-109x(25)00319-5 · Cited by 7
Berling, M., Chaudhary, M. A., Yuan, Y., Varol, N., Dale, P., Testa, E., Klint, J., Lee, A., Lubinga, S. J., & Penrod, J. R. (2022) · Journal of Medical Economics · doi:10.1080/13696998.2022.2077549 · Cited by 7
Projecting the potential cost-effectiveness of dapagliflozin for chronic kidney disease in Kuwait
Swidan, A. K., Elsisi, G. H., Ibrahim, M. M., Aljazzar, M., & Sallam, H. T. (2023) · Journal of Medical Economics · doi:10.1080/13696998.2023.2174749 · Cited by 7
Brander, R. L., Puett, C., Becquey, E., Leroy, J. L., Ruel, M. T., Sessou, F. E., & Huybregts, L. (2024) · Journal of Nutrition · doi:10.1016/j.tjnut.2024.04.010 · Cited by 7
Cao, H.-L., Pham, D. D., Lưu, T. H., Le, P. H., Nguyen, Q. T., Thien, T. P. T., Nguyễn, M. P., Nguyen, H.-D., & Nguyen, C.-N. (2024) · Disability and Rehabilitation Assistive Technology · doi:10.1080/17483107.2024.2378057 · Cited by 7
Ilboudo, P. G., Donfouet, H. P. P., Wilunda, C., Cichon, B., Daniel, T., Njiru, J., Keane, E., Mwangi, B., Mwaniki, E., Zerfu, T. A., et al. (2024) · Maternal and Child Nutrition · doi:10.1111/mcn.13695 · Cited by 7
Quynh, V., Lindholm, L. H., Minh, H. V., Sun, S., Giang, K. B., & Sahlèn, K.-G. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-083895 · Cited by 7
Edwards, H. B., Rejon, C. S., McLeod, H., Hill, E., Opmeer, B. C., Peters, C., Odd, D., de Vocht, F., & Luyt, K. (2025) · BMJ Quality & Safety · doi:10.1136/bmjqs-2024-017763 · Cited by 16
Nguyen, C., Lairson, D. R., Swartz, M. D., & Du, X. L. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.25.2.225 · Cited by 7
TeCHO+ program in Gujarat: a protocol for health technology assessment
Saha, S., Kotwani, P., Pandya, A., Saxena, D. B., Puwar, T. I., Desai, S., Vaghela, P. C., Patel, D., Patel, C. D., Raval, D. A., et al. (2020) · BMJ Innovations · doi:10.1136/bmjinnov-2019-000363 · Cited by 7
LaFontaine, P. R., Yuan, J., Prioli, K. M., Shah, P., Herman, J. H., & Pizzi, L. T. (2021) · Applied Health Economics and Health Policy · doi:10.1007/s40258-020-00612-6 · Cited by 7
Vannabouathong, C., Zhu, M. T., Chang, Y., & Bhandari, M. (2021) · Clinical Medicine Insights Arthritis and Musculoskeletal Disorders · doi:10.1177/11795441211002492 · Cited by 7
Engels, T., Trotignon, G., Agyemang, D., Khan, I., Puthy, K., Roolvink, L., & Schmidt, E. (2021) · Health Policy OPEN · doi:10.1016/j.hpopen.2021.100043 · Cited by 7
Ayati, N., Fleifel, L., Sahraian, M. A., & Nikfar, S. (2021) · Current Journal of Neurology · doi:10.18502/cjn.v20i3.7690 · Cited by 7
Azahar, S. N., Sulong, S., Zaidi, W. A. W., Muhammad, N., Kamisah, Y., & Masbah, N. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031078 · Cited by 7
Pietzsch, J. B., Geisler, B. P., Iken, A. R., van Wijck, I., Holewijn, S., & Reijnen, M. M. P. J. (2022) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-021-03050-6 · Cited by 7
Faramarzi, M. R., fard, S. B., Bayati, M., Jafarlou, F., Parhizgar, M., Rezaee, M., & Keshavarz, K. (2022) · BMC Pediatrics · doi:10.1186/s12887-022-03384-1 · Cited by 7
Carvalho, N., Sousa, T. V., Mizdrak, A., Jones, A. C., Wilson, N., & Blakely, T. A. (2022) · Population Health Metrics · doi:10.1186/s12963-022-00294-3 · Cited by 7
Lee, J.-S., Mogasale, V., Kim, S., Cannon, J. W., Giannini, F., Abbas, K., Excler, J., & Kim, J. H. (2023) · npj Vaccines · doi:10.1038/s41541-023-00718-7 · Cited by 7
The potential health and economic impact of improving stroke care standards for Australia
Kim, J., Andrew, N. E., Thrift, A. G., Bernhardt, J. A., Lindley, R. I., & Cadilhac, D. A.-M. (2017) · International Journal of Stroke · doi:10.1177/1747493017700662 · Cited by 7
Cost-effectiveness of Ovarian Cancer Prevention Strategies
Kwon, J. S. (2017) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000317 · Cited by 7
Designing robot-assisted neurorehabilitation strategies for people with both HIV and stroke
Bui, K. D.-K., & Johnson, M. J. (2018) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-018-0418-3 · Cited by 7
Boyer, S., Nishimwe, M. L., Sagaon‐Teyssier, L., March, L., Koulla‐Shiro, S., Bousmah, M., Toby, R., Mpoudi-Etame, M., Gueye, N. F. N., Sawadogo, A., et al. (2019) · PharmacoEconomics - Open · doi:10.1007/s41669-019-0157-9 · Cited by 7
Neurostimulation therapies in major depressive disorder: A decision‐analytic model
Teng, M., Khoo, A. L., Zhao, Y. J., Abdin, E., Mok, Y. M., Lim, B. P., & Tor, P. C. (2020) · Early Intervention in Psychiatry · doi:10.1111/eip.13091 · Cited by 7
Metadata
- Authors
- Marseille, E., Larson, B., Kazi, D. S., Kahn, J. G., & Rosen, S.
- Affiliations
- Health Strategies International, 555 Fifty-ninth Street, Oakland, California, 94609, United States of America (USA).
- Boston University (US)
- San Francisco General Hospital (US)
- University of California, San Francisco (US)
- Corresponding author
- Marseille, Elliot
- Venue
- Bulletin of the World Health Organization
- Publisher
- WHO Press
- Published
- 2014-12-15
- Volume
- 93
- Issue
- 2
- Pages
- 118-124
- ISSN
- 0042-9686 (ISSN-L)
- PMC
- PMC4339959
- OpenAlex
- W2133104890
- Cited by
- 851
- References
- 42
- Citations by year
- 2026: 45 · 2025: 68 · 2024: 58 · 2023: 69 · 2022: 93 · 2021: 101 · 2020: 100 · 2019: 105 · 2018: 76 · 2017: 78 · 2016: 40 · 2015: 18
- FWCI
- 112.73
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Bulletin of the World Health Organization (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Mental Health (P30MH062246)
- National Institute on Drug Abuse (R01DA015612)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Global Health Care Issues
- Keywords
- cost-effectiveness threshold, WHO-CHOICE, disability-adjusted life years, GDP per capita, healthcare resource allocation, public health decision-making, affordability, cost-effectiveness analysis
- MeSH terms
- Cost-Benefit Analysis, Developing Countries, Female, Health Priorities, Humans, Pregnancy, Syphilis, Global Health, World Health Organization, HIV Infections, Quality-Adjusted Life Years, Benchmarking, Anti-Retroviral Agents, Insecticide-Treated Bednets, Gross Domestic Product
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
